Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$16M |
| 3 |
JD.com
JD
|
+$15.8M |
| 4 |
Tyson Foods
TSN
|
+$15.6M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$44.2M |
| 2 |
Alibaba
BABA
|
+$34.5M |
| 3 |
AGN
Allergan plc
AGN
|
+$24.6M |
| 4 |
Fidelity National Information Services
FIS
|
+$22.3M |
| 5 |
Danaher
DHR
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 10.42% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Technology | 7.81% |
| 5 | Communication Services | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $752M | 26.13% |
3,656,300
+931,200
| +34% | +$187M |
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $184M | 6.41% |
896,800
-613,700
| -41% | -$123M |
|
|
3
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $133M | 4.62% |
645,900
+639,000
| +9,261% | +$128M |
|
4
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $42.8M | 1.49% |
358,841
-95,321
| -21% | -$11.4M |
|
5
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| $39.5M | 1.38% |
+950,000
| New | +$37.5M |
|
6
Workday
WDAY
$49.4B
| $32.9M | 1.15% |
403,513
-10,645
| -3% | -$919K |
|
7
Meta Platforms (Facebook)
META
$1.4T
| $28.1M | 0.98% |
360,398
+29,400
| +9% | +$2.25M |
|
|
8
JD.com
JD
$39.7B
| $27.2M | 0.94% |
1,173,483
+642,621
| +121% | +$15.8M |
|
|
9
Tyson Foods
TSN
$20.6B
| $26.8M | 0.93% |
669,400
+385,212
| +136% | +$15.6M |
|
10
Lennox International
LII
$13.9B
| $20.2M | 0.7% |
212,485
-110,760
| -34% | -$9.84M |
|
|
11
Alibaba
BABA
$286B
| $19.2M | 0.67% |
185,000
-335,750
| -64% | -$34.5M |
|
|
PGNX
12
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $17.9M | 0.62% |
2,370,503
+14,411
| +0.6% | +$86.2K |
|
|
HRC
13
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $17.3M | 0.6% |
379,100
+359,942
| +1,879% | +$16M |
|
14
Baidu
BIDU
$31.6B
| $16.6M | 0.58% |
72,989
+25,689
| +54% | +$5.89M |
|
|
SPLK
15
DELISTED
Splunk Inc
SPLK
| $15.4M | 0.54% |
262,069
-6,583
| -2% | -$404K |
|
16
Global Payments
GPN
$24.7B
| $15.4M | 0.53% |
380,894
+52,894
| +16% | +$2.12M |
|
17
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $15.1M | 0.52% |
+381,000
| New | +$15.8M |
|
|
AVNS
18
DELISTED
Avanos Medical
AVNS
| $15M | 0.52% |
+329,108
| New | +$12.9M |
|
19
Union Pacific
UNP
$183B
| $14.6M | 0.51% |
122,176
-35,224
| -22% | -$4.04M |
|
20
Eli Lilly
LLY
$1.12T
| $14.5M | 0.51% |
210,800
+151,800
| +257% | +$10.2M |
|
21
ITT
ITT
$18.6B
| $14.5M | 0.5% |
358,763
+83,663
| +30% | +$3.5M |
|
22
HP
HPQ
$27.2B
| $14.3M | 0.5% |
786,129
-451,732
| -36% | -$7.57M |
|
23
Viatris
VTRS
$18.7B
| $14.3M | 0.5% |
254,152
+234,137
| +1,170% | +$12.6M |
|
24
Bausch Health
BHC
$2.41B
| $14.3M | 0.5% |
100,000
+93,174
| +1,365% | +$12.5M |
|
|
WBC
25
DELISTED
WABCO HOLDINGS INC.
WBC
| $14.1M | 0.49% |
135,000
+110,925
| +461% | +$11M |
|
Similar funds
Paul Tudor Jones's Q4 2014 Portfolio in Review
As of Q4 2014, Paul Tudor Jones held 1,750 positions worth $2.88B, up 3.7% from $2.77B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Paul Tudor Jones's Q4 2014 filing shows 423 new, 490 increased, 477 reduced and 333 closed positions. Its largest new stake was LinkedIn Corporation: 61,500 shares worth $14.1M. The largest sale was Zimmer Biomet, an estimated $44.2M.
By sector, the portfolio is most concentrated in Industrials at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Paul Tudor Jones's largest Q4 2014 buy was LinkedIn Corporation: 61,500 shares worth $14.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $128M increase.
- Paul Tudor Jones's biggest Q4 2014 reduction was Zimmer Biomet, cutting an estimated $44.2M.
- Paul Tudor Jones fully exited Fidelity National Information Services in Q4 2014, selling an estimated $22.3M.
- Paul Tudor Jones's ten largest holdings make up 45% of its $2.88B portfolio in Q4 2014.
- Paul Tudor Jones opened 423 new positions and closed 333 in Q4 2014.
- Paul Tudor Jones's portfolio value rose 3.7% quarter-over-quarter to $2.88B.
Based on Tudor Investment Corp's 13F filing for Q4 2014, filed 17 Feb 2015.